<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT944-1676</title>
	</head>
	<body>
		<main>
			<p>941219 FT  19 DEC 94 / UK Company News: Haemocell In a year of 'consolidation and change', Haemocell, the USM-quoted medical equipment maker, incurred increased pre-tax losses of Pounds 2.35m against Pounds 2.13m for the 12 months to August 31. The primary task, according to Mr Andrew Priestly, chairman, had been to restructure operations and establish an international sales and distribution network. Turnover was Pounds 212,000, compared with Pounds 1.12m which included an exclusive distributor's inventory, most of which was repurchased or returned as part of the termination agreement. The company's priority remained to market its System 350 blood transfusion device, Mr Priestly said. Losses per share were 10.9p (10.1p).</p>
		</main>
</body></html>
            